glp 1 and weight loss Study finds GLP-1 receptor agonists target fat over muscle for GLP-1 weight loss drugs leave

889 Inhibition of the Wnt signal hinders osteogenic differentiation by affecting the Smad and MAPK signaling pathways

Continuous glucose monitoring technology with and without insulin pump therapy is an emerging attractive approach to help insulin-treated people with DKD optimise their glycaemic control

By slowing the movement of stomach contents, GLP-1 medications can significantly delay gastric emptying, with the effect being most pronounced during dose escalation

Not painful Once the needle is through the skin, there are few nerve sensors, making the injection almost painless

Richness of human gut microbiome correlates with metabolic markers (in Eng)

Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins